SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
SI-BONE (Nasdaq: SIBN) will present at the Piper Sandler 37th Annual Healthcare Conference in New York on December 2, 2025. Management will host a fireside chat at 9:00 a.m. Pacific / 12:00 p.m. Eastern.
Investors can register to listen and access a live audio webcast via the company’s Investors website. The webcast will be archived and available for replay for at least 90 days after the event.
SI-BONE (Nasdaq: SIBN) parteciperà alla 37ª Conferenza Annuale sull'Healthcare di Piper Sandler a New York il 2 dicembre 2025. Il management terrà una chiacchierata informale alle 9:00 a.m. Pacifico / 12:00 p.m. Eastern.
Gli investitori possono registrarsi per ascoltare e accedere a una webcast audio in diretta tramite il sito Investors dell'azienda. La webcast sarà archiviata e disponibile per la replica per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN) participará en la 37ª Conferencia Anual de Salud de Piper Sandler en Nueva York el 2 de diciembre de 2025. La dirección organizará una charla informal a las 9:00 a.m. Pacífico / 12:00 p.m. Este.
Los inversionistas pueden registrarse para escuchar y acceder a una transmisión de audio en vivo a través del sitio web Investors de la empresa. La transmisión quedará archivada y estará disponible para su reproducción durante al menos 90 días después del evento.
SI-BONE (나스닥: SIBN)은 뉴욕에서 열리는 Piper Sandler 37th Annual Healthcare Conference에 발표할 예정이며, 2025년 12월 2일에 개최됩니다. 경영진은 미서부시각 9:00 / 동부시각 12:00에 파이어사이드 챗을 진행합니다.
투자자들은 회사의 Investors 웹사이트를 통해 청취 등록을 하고 라이브 오디오 생중계를 이용할 수 있습니다. 생중계는 행사 후 최소 90일 간 보관되어 재생할 수 있습니다.
SI-BONE (Nasdaq: SIBN) participera à la 37e Conférence annuelle sur les soins de santé de Piper Sandler à New York le 2 décembre 2025. La direction animera une discussion informelle à 9h00 Pacifique / 12h00 Heure de l'Est.
Les investisseurs peuvent s'inscrire pour écouter et accéder à une diffusion audio en direct via le site Investors de l'entreprise. La diffusion sera archivée et disponible en replay pendant au moins 90 jours après l'événement.
SI-BONE (Nasdaq: SIBN) wird auf der Piper Sandler 37th Annual Healthcare Conference in New York am 2. Dezember 2025 auftreten. Die Geschäftsführung wird ein Fireside-Chat um 9:00 Uhr Pacific / 12:00 Uhr Eastern führen.
Investoren können sich registrieren, um zuzuhören und per die Audio-Live-Übertragung über die Website des Unternehmens Investors zuzugreifen. Die Übertragung wird archiviert und für mindestens 90 Tage nach der Veranstaltung zur Wiedergabe verfügbar sein.
SI-BONE (بورصة ناسداك: SIBN) ستشارك في المؤتمر الصحي السنوي السابع والثلاثين لبير سايندلر في نيويورك يوم 2 ديسمبر 2025. ستعقد الإدارة محادثة حوار غير رسمية في 9:00 صباحاً بتوقيت المحيط الهادئ / 12:00 ظهراً بتوقيت شرق الولايات المتحدة.
يمكن للمستثمرين التسجيل للاستماع والوصول إلى بث صوتي مباشر عبر موقع الشركة Investors. سيُؤرشف البث وسيكون متاحاً لإعادة التشغيل لمدة لا تقل عن 90 يوماً بعد الحدث.
- None.
- None.
SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time/ 12:00 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: SIBN Investors. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System®, SI-BONE has supported over 4,900 physicians in performing a total of over 135,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies with over 180 peer reviewed publications including four randomized controlled trials. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE, Sacropelvic Solutions, iFuse Implant System®, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When will SI-BONE (SIBN) present at the Piper Sandler 2025 conference?
What time is the SI-BONE (SIBN) fireside chat on December 2, 2025?
How can investors listen to the SI-BONE (SIBN) webcast on December 2, 2025?
Will the SI-BONE (SIBN) webcast be available after the conference?
Who from SI-BONE (SIBN) will speak at the Piper Sandler conference?
